ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IBS-C Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-36N2139
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IBS C Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global IBS-C Drugs Market Research Report 2025

Code: QYRE-Auto-36N2139
Report
August 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Catalent Pharmaceuticals Solutions
Nestle S A
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx Inc
Synthetic Biologics Inc.
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring
Ironwood Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca plc
The Menarini Group
Ono Pharmaceutical Co Ltd

IBS-C Drugs Market

The global market for IBS-C Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for IBS-C Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for IBS-C Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of IBS-C Drugs include Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IBS-C Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IBS-C Drugs.
The IBS-C Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IBS-C Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IBS-C Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IBS-C Drugs Market Report

Report Metric Details
Report Name IBS-C Drugs Market
Segment by Type
  • Linaclotide
  • Lubiprostone
  • Osmotic Laxatives
  • Stimulant Laxatives
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, Bama-Geve, SLU, Ferring BV, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals Ltd, Norgine B.V, Prometheus Laboratories Inc, Actavis Nordic A/S, Albireo Pharma Inc, Yuhan Corp, Astrazeneca Plc, The Menarini Group, Ono Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IBS-C Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IBS-C Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IBS-C Drugs Market report?

Ans: The main players in the IBS-C Drugs Market are Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc, Synthetic Biologics, Inc, Teva Pharmaceutical Industries, Bama-Geve, SLU, Ferring BV, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals Ltd, Norgine B.V, Prometheus Laboratories Inc, Actavis Nordic A/S, Albireo Pharma Inc, Yuhan Corp, Astrazeneca Plc, The Menarini Group, Ono Pharmaceutical Co., Ltd

What are the Application segmentation covered in the IBS-C Drugs Market report?

Ans: The Applications covered in the IBS-C Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the IBS-C Drugs Market report?

Ans: The Types covered in the IBS-C Drugs Market report are Linaclotide, Lubiprostone, Osmotic Laxatives, Stimulant Laxatives, Others

1 IBS-C Drugs Market Overview
1.1 Product Definition
1.2 IBS-C Drugs by Type
1.2.1 Global IBS-C Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Linaclotide
1.2.3 Lubiprostone
1.2.4 Osmotic Laxatives
1.2.5 Stimulant Laxatives
1.2.6 Others
1.3 IBS-C Drugs by Application
1.3.1 Global IBS-C Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drugs Market Size Estimates and Forecasts
1.4.1 Global IBS-C Drugs Revenue 2020-2031
1.4.2 Global IBS-C Drugs Sales 2020-2031
1.4.3 Global IBS-C Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 IBS-C Drugs Market Competition by Manufacturers
2.1 Global IBS-C Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global IBS-C Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global IBS-C Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of IBS-C Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IBS-C Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IBS-C Drugs, Product Type & Application
2.7 Global Key Manufacturers of IBS-C Drugs, Date of Enter into This Industry
2.8 Global IBS-C Drugs Market Competitive Situation and Trends
2.8.1 Global IBS-C Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IBS-C Drugs Players Market Share by Revenue
2.8.3 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IBS-C Drugs Market Scenario by Region
3.1 Global IBS-C Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global IBS-C Drugs Sales by Region: 2020-2031
3.2.1 Global IBS-C Drugs Sales by Region: 2020-2025
3.2.2 Global IBS-C Drugs Sales by Region: 2026-2031
3.3 Global IBS-C Drugs Revenue by Region: 2020-2031
3.3.1 Global IBS-C Drugs Revenue by Region: 2020-2025
3.3.2 Global IBS-C Drugs Revenue by Region: 2026-2031
3.4 North America IBS-C Drugs Market Facts & Figures by Country
3.4.1 North America IBS-C Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America IBS-C Drugs Sales by Country (2020-2031)
3.4.3 North America IBS-C Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe IBS-C Drugs Market Facts & Figures by Country
3.5.1 Europe IBS-C Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe IBS-C Drugs Sales by Country (2020-2031)
3.5.3 Europe IBS-C Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IBS-C Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific IBS-C Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific IBS-C Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific IBS-C Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America IBS-C Drugs Market Facts & Figures by Country
3.7.1 Latin America IBS-C Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America IBS-C Drugs Sales by Country (2020-2031)
3.7.3 Latin America IBS-C Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IBS-C Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IBS-C Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa IBS-C Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa IBS-C Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global IBS-C Drugs Sales by Type (2020-2031)
4.1.1 Global IBS-C Drugs Sales by Type (2020-2025)
4.1.2 Global IBS-C Drugs Sales by Type (2026-2031)
4.1.3 Global IBS-C Drugs Sales Market Share by Type (2020-2031)
4.2 Global IBS-C Drugs Revenue by Type (2020-2031)
4.2.1 Global IBS-C Drugs Revenue by Type (2020-2025)
4.2.2 Global IBS-C Drugs Revenue by Type (2026-2031)
4.2.3 Global IBS-C Drugs Revenue Market Share by Type (2020-2031)
4.3 Global IBS-C Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global IBS-C Drugs Sales by Application (2020-2031)
5.1.1 Global IBS-C Drugs Sales by Application (2020-2025)
5.1.2 Global IBS-C Drugs Sales by Application (2026-2031)
5.1.3 Global IBS-C Drugs Sales Market Share by Application (2020-2031)
5.2 Global IBS-C Drugs Revenue by Application (2020-2031)
5.2.1 Global IBS-C Drugs Revenue by Application (2020-2025)
5.2.2 Global IBS-C Drugs Revenue by Application (2026-2031)
5.2.3 Global IBS-C Drugs Revenue Market Share by Application (2020-2031)
5.3 Global IBS-C Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Catalent Pharmaceuticals Solutions
6.1.1 Catalent Pharmaceuticals Solutions Company Information
6.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview
6.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolio
6.1.5 Catalent Pharmaceuticals Solutions Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Company Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nestle IBS-C Drugs Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories IBS-C Drugs Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Synergy Pharmaceuticals
6.4.1 Synergy Pharmaceuticals Company Information
6.4.2 Synergy Pharmaceuticals Description and Business Overview
6.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Synergy Pharmaceuticals IBS-C Drugs Product Portfolio
6.4.5 Synergy Pharmaceuticals Recent Developments/Updates
6.5 Sucampo Pharmaceuticals
6.5.1 Sucampo Pharmaceuticals Company Information
6.5.2 Sucampo Pharmaceuticals Description and Business Overview
6.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sucampo Pharmaceuticals IBS-C Drugs Product Portfolio
6.5.5 Sucampo Pharmaceuticals Recent Developments/Updates
6.6 Novartis Pharma Ag
6.6.1 Novartis Pharma Ag Company Information
6.6.2 Novartis Pharma Ag Description and Business Overview
6.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Pharma Ag IBS-C Drugs Product Portfolio
6.6.5 Novartis Pharma Ag Recent Developments/Updates
6.7 Astellas Pharmaceuticals
6.7.1 Astellas Pharmaceuticals Company Information
6.7.2 Astellas Pharmaceuticals Description and Business Overview
6.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Astellas Pharmaceuticals IBS-C Drugs Product Portfolio
6.7.5 Astellas Pharmaceuticals Recent Developments/Updates
6.8 Ardelyx, Inc
6.8.1 Ardelyx, Inc Company Information
6.8.2 Ardelyx, Inc Description and Business Overview
6.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ardelyx, Inc IBS-C Drugs Product Portfolio
6.8.5 Ardelyx, Inc Recent Developments/Updates
6.9 Synthetic Biologics, Inc
6.9.1 Synthetic Biologics, Inc Company Information
6.9.2 Synthetic Biologics, Inc Description and Business Overview
6.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Synthetic Biologics, Inc IBS-C Drugs Product Portfolio
6.9.5 Synthetic Biologics, Inc Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Industries IBS-C Drugs Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Bama-Geve, SLU
6.11.1 Bama-Geve, SLU Company Information
6.11.2 Bama-Geve, SLU Description and Business Overview
6.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bama-Geve, SLU IBS-C Drugs Product Portfolio
6.11.5 Bama-Geve, SLU Recent Developments/Updates
6.12 Ferring BV
6.12.1 Ferring BV Company Information
6.12.2 Ferring BV Description and Business Overview
6.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ferring BV IBS-C Drugs Product Portfolio
6.12.5 Ferring BV Recent Developments/Updates
6.13 Ironwood Pharmaceuticals, Inc
6.13.1 Ironwood Pharmaceuticals, Inc Company Information
6.13.2 Ironwood Pharmaceuticals, Inc Description and Business Overview
6.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Portfolio
6.13.5 Ironwood Pharmaceuticals, Inc Recent Developments/Updates
6.14 Salix Pharmaceuticals Ltd
6.14.1 Salix Pharmaceuticals Ltd Company Information
6.14.2 Salix Pharmaceuticals Ltd Description and Business Overview
6.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolio
6.14.5 Salix Pharmaceuticals Ltd Recent Developments/Updates
6.15 Norgine B.V
6.15.1 Norgine B.V Company Information
6.15.2 Norgine B.V Description and Business Overview
6.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Norgine B.V IBS-C Drugs Product Portfolio
6.15.5 Norgine B.V Recent Developments/Updates
6.16 Prometheus Laboratories Inc
6.16.1 Prometheus Laboratories Inc Company Information
6.16.2 Prometheus Laboratories Inc Description and Business Overview
6.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Prometheus Laboratories Inc IBS-C Drugs Product Portfolio
6.16.5 Prometheus Laboratories Inc Recent Developments/Updates
6.17 Actavis Nordic A/S
6.17.1 Actavis Nordic A/S Company Information
6.17.2 Actavis Nordic A/S Description and Business Overview
6.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Actavis Nordic A/S IBS-C Drugs Product Portfolio
6.17.5 Actavis Nordic A/S Recent Developments/Updates
6.18 Albireo Pharma Inc
6.18.1 Albireo Pharma Inc Company Information
6.18.2 Albireo Pharma Inc Description and Business Overview
6.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Albireo Pharma Inc IBS-C Drugs Product Portfolio
6.18.5 Albireo Pharma Inc Recent Developments/Updates
6.19 Yuhan Corp
6.19.1 Yuhan Corp Company Information
6.19.2 Yuhan Corp Description and Business Overview
6.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Yuhan Corp IBS-C Drugs Product Portfolio
6.19.5 Yuhan Corp Recent Developments/Updates
6.20 Astrazeneca Plc
6.20.1 Astrazeneca Plc Company Information
6.20.2 Astrazeneca Plc Description and Business Overview
6.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Astrazeneca Plc IBS-C Drugs Product Portfolio
6.20.5 Astrazeneca Plc Recent Developments/Updates
6.21 The Menarini Group
6.21.1 The Menarini Group Company Information
6.21.2 The Menarini Group Description and Business Overview
6.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 The Menarini Group IBS-C Drugs Product Portfolio
6.21.5 The Menarini Group Recent Developments/Updates
6.22 Ono Pharmaceutical Co., Ltd
6.22.1 Ono Pharmaceutical Co., Ltd Company Information
6.22.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Portfolio
6.22.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IBS-C Drugs Industry Chain Analysis
7.2 IBS-C Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IBS-C Drugs Production Mode & Process Analysis
7.4 IBS-C Drugs Sales and Marketing
7.4.1 IBS-C Drugs Sales Channels
7.4.2 IBS-C Drugs Distributors
7.5 IBS-C Drugs Customer Analysis
8 IBS-C Drugs Market Dynamics
8.1 IBS-C Drugs Industry Trends
8.2 IBS-C Drugs Market Drivers
8.3 IBS-C Drugs Market Challenges
8.4 IBS-C Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Catalent Pharmaceuticals Solutions
Nestle S A
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx Inc
Synthetic Biologics Inc.
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring
Ironwood Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca plc
The Menarini Group
Ono Pharmaceutical Co Ltd
List of Tables
 Table 1. Global IBS-C Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global IBS-C Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global IBS-C Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global IBS-C Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global IBS-C Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global IBS-C Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global IBS-C Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market IBS-C Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of IBS-C Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IBS-C Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IBS-C Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of IBS-C Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IBS-C Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS-C Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IBS-C Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global IBS-C Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global IBS-C Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global IBS-C Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global IBS-C Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global IBS-C Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global IBS-C Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global IBS-C Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global IBS-C Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America IBS-C Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America IBS-C Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America IBS-C Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America IBS-C Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe IBS-C Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe IBS-C Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe IBS-C Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe IBS-C Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific IBS-C Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific IBS-C Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific IBS-C Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific IBS-C Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific IBS-C Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America IBS-C Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America IBS-C Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America IBS-C Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America IBS-C Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa IBS-C Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa IBS-C Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa IBS-C Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa IBS-C Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global IBS-C Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global IBS-C Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global IBS-C Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global IBS-C Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global IBS-C Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global IBS-C Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global IBS-C Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global IBS-C Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global IBS-C Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global IBS-C Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global IBS-C Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global IBS-C Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global IBS-C Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global IBS-C Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global IBS-C Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global IBS-C Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global IBS-C Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global IBS-C Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global IBS-C Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global IBS-C Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Catalent Pharmaceuticals Solutions Company Information
 Table 71. Catalent Pharmaceuticals Solutions Description and Business Overview
 Table 72. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Catalent Pharmaceuticals Solutions IBS-C Drugs Product
 Table 74. Catalent Pharmaceuticals Solutions Recent Developments/Updates
 Table 75. Nestle Company Information
 Table 76. Nestle Description and Business Overview
 Table 77. Nestle IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Nestle IBS-C Drugs Product
 Table 79. Nestle Recent Developments/Updates
 Table 80. Abbott Laboratories Company Information
 Table 81. Abbott Laboratories Description and Business Overview
 Table 82. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Abbott Laboratories IBS-C Drugs Product
 Table 84. Abbott Laboratories Recent Developments/Updates
 Table 85. Synergy Pharmaceuticals Company Information
 Table 86. Synergy Pharmaceuticals Description and Business Overview
 Table 87. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Synergy Pharmaceuticals IBS-C Drugs Product
 Table 89. Synergy Pharmaceuticals Recent Developments/Updates
 Table 90. Sucampo Pharmaceuticals Company Information
 Table 91. Sucampo Pharmaceuticals Description and Business Overview
 Table 92. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Sucampo Pharmaceuticals IBS-C Drugs Product
 Table 94. Sucampo Pharmaceuticals Recent Developments/Updates
 Table 95. Novartis Pharma Ag Company Information
 Table 96. Novartis Pharma Ag Description and Business Overview
 Table 97. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Novartis Pharma Ag IBS-C Drugs Product
 Table 99. Novartis Pharma Ag Recent Developments/Updates
 Table 100. Astellas Pharmaceuticals Company Information
 Table 101. Astellas Pharmaceuticals Description and Business Overview
 Table 102. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Astellas Pharmaceuticals IBS-C Drugs Product
 Table 104. Astellas Pharmaceuticals Recent Developments/Updates
 Table 105. Ardelyx, Inc Company Information
 Table 106. Ardelyx, Inc Description and Business Overview
 Table 107. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Ardelyx, Inc IBS-C Drugs Product
 Table 109. Ardelyx, Inc Recent Developments/Updates
 Table 110. Synthetic Biologics, Inc Company Information
 Table 111. Synthetic Biologics, Inc Description and Business Overview
 Table 112. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Synthetic Biologics, Inc IBS-C Drugs Product
 Table 114. Synthetic Biologics, Inc Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Company Information
 Table 116. Teva Pharmaceutical Industries Description and Business Overview
 Table 117. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Industries IBS-C Drugs Product
 Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 120. Bama-Geve, SLU Company Information
 Table 121. Bama-Geve, SLU Description and Business Overview
 Table 122. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Bama-Geve, SLU IBS-C Drugs Product
 Table 124. Bama-Geve, SLU Recent Developments/Updates
 Table 125. Ferring BV Company Information
 Table 126. Ferring BV Description and Business Overview
 Table 127. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Ferring BV IBS-C Drugs Product
 Table 129. Ferring BV Recent Developments/Updates
 Table 130. Ironwood Pharmaceuticals, Inc Company Information
 Table 131. Ironwood Pharmaceuticals, Inc Description and Business Overview
 Table 132. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product
 Table 134. Ironwood Pharmaceuticals, Inc Recent Developments/Updates
 Table 135. Salix Pharmaceuticals Ltd Company Information
 Table 136. Salix Pharmaceuticals Ltd Description and Business Overview
 Table 137. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Salix Pharmaceuticals Ltd IBS-C Drugs Product
 Table 139. Salix Pharmaceuticals Ltd Recent Developments/Updates
 Table 140. Norgine B.V Company Information
 Table 141. Norgine B.V Description and Business Overview
 Table 142. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Norgine B.V IBS-C Drugs Product
 Table 144. Norgine B.V Recent Developments/Updates
 Table 145. Prometheus Laboratories Inc Company Information
 Table 146. Prometheus Laboratories Inc Description and Business Overview
 Table 147. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Prometheus Laboratories Inc IBS-C Drugs Product
 Table 149. Prometheus Laboratories Inc Recent Developments/Updates
 Table 150. Actavis Nordic A/S Company Information
 Table 151. Actavis Nordic A/S Description and Business Overview
 Table 152. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. Actavis Nordic A/S IBS-C Drugs Product
 Table 154. Actavis Nordic A/S Recent Developments/Updates
 Table 155. Albireo Pharma Inc Company Information
 Table 156. Albireo Pharma Inc Description and Business Overview
 Table 157. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. Albireo Pharma Inc IBS-C Drugs Product
 Table 159. Albireo Pharma Inc Recent Developments/Updates
 Table 160. Yuhan Corp Company Information
 Table 161. Yuhan Corp Description and Business Overview
 Table 162. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 163. Yuhan Corp IBS-C Drugs Product
 Table 164. Yuhan Corp Recent Developments/Updates
 Table 165. Astrazeneca Plc Company Information
 Table 166. Astrazeneca Plc Description and Business Overview
 Table 167. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 168. Astrazeneca Plc IBS-C Drugs Product
 Table 169. Astrazeneca Plc Recent Developments/Updates
 Table 170. The Menarini Group Company Information
 Table 171. The Menarini Group Description and Business Overview
 Table 172. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 173. The Menarini Group IBS-C Drugs Product
 Table 174. The Menarini Group Recent Developments/Updates
 Table 175. Ono Pharmaceutical Co., Ltd Company Information
 Table 176. Ono Pharmaceutical Co., Ltd Description and Business Overview
 Table 177. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 178. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product
 Table 179. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. IBS-C Drugs Distributors List
 Table 183. IBS-C Drugs Customers List
 Table 184. IBS-C Drugs Market Trends
 Table 185. IBS-C Drugs Market Drivers
 Table 186. IBS-C Drugs Market Challenges
 Table 187. IBS-C Drugs Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IBS-C Drugs
 Figure 2. Global IBS-C Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global IBS-C Drugs Market Share by Type: 2024 & 2031
 Figure 4. Linaclotide Product Picture
 Figure 5. Lubiprostone Product Picture
 Figure 6. Osmotic Laxatives Product Picture
 Figure 7. Stimulant Laxatives Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global IBS-C Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global IBS-C Drugs Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Global IBS-C Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global IBS-C Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global IBS-C Drugs Sales (2020-2031) & (K Pcs)
 Figure 17. Global IBS-C Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 18. IBS-C Drugs Report Years Considered
 Figure 19. IBS-C Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global IBS-C Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest IBS-C Drugs Players: Market Share by Revenue in IBS-C Drugs in 2024
 Figure 22. IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global IBS-C Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America IBS-C Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America IBS-C Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe IBS-C Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe IBS-C Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific IBS-C Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific IBS-C Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America IBS-C Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America IBS-C Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa IBS-C Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa IBS-C Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E IBS-C Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of IBS-C Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of IBS-C Drugs by Type (2020-2031)
 Figure 59. Global IBS-C Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of IBS-C Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of IBS-C Drugs by Application (2020-2031)
 Figure 62. Global IBS-C Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 63. IBS-C Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Irritable Bowel Syndrome Drug Market Research Report 2024
Global IBS Implant Market Research Report 2024
Global Chronic Idiopathic Constipation Drugs Market Research Report 2024
Global Irritable Bowel Syndrome Medication Market Research Report 2025
Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030
Global Digestive System Drugs Market Research Report 2024
Global Chronic Constipation Treatment Drugs Market Research Report 2024
Global Constipation Treatment Drug Market Research Report 2025
Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030
Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Famotidine Drugs Market Research Report 2025
Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Stomach Acid Suppressing Drug Market Research Report 2024
Chronic Idiopathic Constipation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCC Drug Market Research Report 2024
Global Interstitial Cystitis Drugs Market Research Report 2024
Global Niclosamide Market Research Report 2024
Global Anxiolytic Drugs Market Research Report 2025
Global Nitisinone Drug Market Research Report 2024
Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions